Literature DB >> 15184210

Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapy.

Robert M Jasmer1, Christopher B Seaman, Leah C Gonzalez, L Masae Kawamura, Dennis H Osmond, Charles L Daley.   

Abstract

Effective treatment of tuberculosis requires adherence to a minimum of 6 months treatment with multiple drugs. To improve adherence and cure rates, directly observed therapy is recommended for the treatment of pulmonary tuberculosis. We compared treatment outcomes among all culture-positive patients treated for active pulmonary tuberculosis (n = 372) in San Francisco County, California from 1998 through 2000. Patients treated by directly observed therapy at the start of therapy (n = 149) had a significantly higher cure rate compared with patients treated by self-administered therapy (n = 223) (the sum of bacteriologic cure and completion of treatment, 97.8% versus 88.6%, p < 0.002), and decreased tuberculosis-related mortality (0% vs. 5.5%, p = 0.002). Rates of treatment failure, relapse, and acquired drug resistance were similar between the two groups. Forty-four percent of patients who received self-administered therapy had risk factors for nonadherence and should have been assigned to directly observed therapy. We conclude that treatment plans that emphasize directly observed therapy from the start of therapy have the greatest success in improving tuberculosis treatment outcomes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184210     DOI: 10.1164/rccm.200401-095OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  35 in total

1.  Mental and behavioral health legal preparedness in major emergencies.

Authors:  James G Hodge; Lainie Rutkow; Aubrey Joy Corcoran
Journal:  Public Health Rep       Date:  2010 Sep-Oct       Impact factor: 2.792

2.  Caveat emptor? Meta-analysis of studies comparing self-observed therapy and directly observed therapy for tuberculosis.

Authors:  Patrick K Moonan; Stephen E Weis
Journal:  Clin Infect Dis       Date:  2013-06-27       Impact factor: 9.079

3.  Exposure to bioterrorism and mental health response among staff on Capitol Hill.

Authors:  Carol S North; Betty Pfefferbaum; Meena Vythilingam; Gregory J Martin; John K Schorr; Angela S Boudreaux; Edward L Spitznagel; Barry A Hong
Journal:  Biosecur Bioterror       Date:  2009-12

4.  DOT associated with reduced all-cause mortality among tuberculosis patients in Taipei, Taiwan, 2006-2008.

Authors:  Y-F Yen; T C Rodwell; M-Y Yen; H-C Shih; B-S Hu; L-H Li; Y-H Shie; P Chuang; R S Garfein
Journal:  Int J Tuberc Lung Dis       Date:  2012-02       Impact factor: 2.373

5.  Antituberculosis drug resistance acquired during treatment: an analysis of cases reported in California, 1994-2006.

Authors:  Travis C Porco; Peter Oh; Jennifer M Flood
Journal:  Clin Infect Dis       Date:  2012-12-07       Impact factor: 9.079

6.  Factors associated with mortality in patients with tuberculosis.

Authors:  David J Horne; Rebecca Hubbard; Masahiro Narita; Alexia Exarchos; David R Park; Christopher H Goss
Journal:  BMC Infect Dis       Date:  2010-08-27       Impact factor: 3.090

7.  Efficacy of nurse case-managed intervention for latent tuberculosis among homeless subsamples.

Authors:  Adeline Nyamathi; Payam Nahid; Jill Berg; Joe Burrage; Ashley Christiani; Salah Aqtash; Donald Morisky; Barbara Leake
Journal:  Nurs Res       Date:  2008 Jan-Feb       Impact factor: 2.381

Review 8.  Advances in the diagnosis and treatment of tuberculosis.

Authors:  Payam Nahid; Madhukar Pai; Philip C Hopewell
Journal:  Proc Am Thorac Soc       Date:  2006

9.  Comparison of tuberculosis treatment outcomes by method of treatment supervision in the Fiji Islands.

Authors:  N Narayan; K Viney; S Varman
Journal:  Public Health Action       Date:  2014-09-21

10.  Tuberculosis treatment adherence and fatality in Spain.

Authors:  Joan A Caylà; Teresa Rodrigo; Juan Ruiz-Manzano; José A Caminero; Rafael Vidal; José M García; Rafael Blanquer; Martí Casals
Journal:  Respir Res       Date:  2009-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.